Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Hypertension

Salt: flawed research should not divert actions to reduce intake

Nature Reviews Nephrology volume 12, pages 514–515 (2016)Cite this article

Subjects

A recent study suggests that salt reduction should be confined to hypertensive individuals with high salt intake. However, this study has serious methodological issues and its findings should therefore not challenge the strong evidence supporting the benefits of salt reduction for the general population.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Changes in salt intake (measured by 24 h urinary sodium (UNa) excretion), blood pressure, stroke and ischaemic heart disease (IHD) mortality in England, from 2003 to 2011.

References

  1. Mente, A. et al. Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies. Lancet http://dx.doi.org/10.1016/S0140-6736(16)30467-6 (2016).

  2. He, F. J., Ivkovic, V., Jelakovic, B., Morris, J. & MacGregor, G. A. Estimation of sodium excretion should be made as simple as possible, but not simpler: misleading papers and editorial on spot urines. J. Hypertens. 33, 884–886 (2015).

    Article  CAS  PubMed  Google Scholar 

  3. Cogswell, M. E., Mugavero, K., Bowman, B. A. & Frieden, T. R. Dietary sodium and cardiovascular disease risk — measurement matters. N. Engl. J. Med. http://dx.doi.org/10.1056/NEJMsb1607161 (2016).

  4. He, F. J., Li, J. & MacGregor, G. A. Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials. BMJ 346, f1325 (2013).

    Article  PubMed  Google Scholar 

  5. He, F. J. & MacGregor, G. A. How far should salt intake be reduced? Hypertension 42, 1093–10999 (2003).

    Article  CAS  PubMed  Google Scholar 

  6. He, F. J. & MacGregor, G. A. Salt reduction lowers cardiovascular risk: meta-analysis of outcome trials. Lancet 378, 380–382 (2011).

    Article  PubMed  Google Scholar 

  7. He, F. J., Pombo-Rodrigues, S. & MacGregor, G. A. Salt reduction in England from 2003 to 2011: its relationship to blood pressure, stroke and ischaemic heart disease mortality. BMJ Open 4, e004549 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  8. National Institute for Health and Clinical Excellence (NICE). Cardiovascular disease prevention. http://guidance.nice.org.uk/PH25 (2010).

  9. U.S. Food and Drug Administration. Sodium reduction. http://www.fda.gov/Food/IngredientsPackagingLabeling/FoodAdditivesIngredients/ucm253316.htm (2016).

  10. Mozaffarian, D. et al. Global sodium consumption and death from cardiovascular causes. N. Engl. J. Med. 371, 624–634 (2014).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Feng J. He and Graham A. MacGregor are at the Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.,

    Feng J. He & Graham A. MacGregor

Authors
  1. Feng J. He
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Graham A. MacGregor
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Feng J. He.

Ethics declarations

Competing interests

F.J.H is a member of Consensus Action on Salt & Health (CASH) and World Action on Salt & Health (WASH). Both CASH and WASH are non-profit charitable organisations. F.J.H does not receive any financial support from CASH or WASH. G.A.M is Chairman of Blood Pressure UK (BPUK), also a non-profit charitable organization, Chairman of CASH and Chairman of WASH. G.A.M does not receive any financial support from any of these organisations.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

He, F., MacGregor, G. Salt: flawed research should not divert actions to reduce intake. Nat Rev Nephrol 12, 514–515 (2016). https://doi.org/10.1038/nrneph.2016.97

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneph.2016.97

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing